Ernexa Therapeutics Inc.: Form 8-K, filed Jul 10, 2017
Filed with the SEC on Jul 10, 2017 and accepted by EDGAR at Jul 10, 2017, 08:36 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-17-007627. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.